Laurus Labs Ltd Completes USFDA Pre Approval Inspectation

Laurus Labs Ltd. (Laurus BSE: 540222, NSE: Lauruslabs, ISIN: INE947Q01010), a leading research and development driven pharmaceutical company has completed the USFDA, Pre Approval Inspection (PAI) for an API manufactured at its Units 1&3, located at J N Pharma City, Parawada, Visakhapatnam, Andhra Pradesh, with three observations, which are procedural in nature.

No data integrity issues were observed in the inspection. The inspection was carried out from 18 November, 2019 – 21 November, 2019.

Shares of Laurus Labs Ltd was last trading in BSE at Rs.334.45 as compared to the previous close of Rs. 332.15. The total number of shares traded during the day was 3479 in over 399 trades.

The stock hit an intraday high of Rs. 344.25 and intraday low of 328. The net turnover during the day was Rs. 1169746.-Equity Bulls